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Lessons from the COVID-19 Pandemic on the Role of Socioeconomic Status
in Health Outcomes
Leila Karout
Current Characteristics and Outcomes of COVID-19
The SARS-CoV-2 (COVID-19) pandemic has evoked extreme
circumstances for many around the world. As of the time of this writing, the
World Health Organization has reported 159,319,384 confirmed cases of
COVID-19 and 3,311,780 deaths globally. The United States alone has seen a
total of 32,424,637 confirmed cases and 576,814 total deaths. 1 While risk factors,
clinical characteristics of patients, mortality, and morbidity are all under
consistent study, the information we have now on the pandemic and its effects on
various populations shows similar patterns and themes. Current research has
shown that severe obesity, hypertension, diabetes, cardiovascular diseases
(CVDs), and kidney disease are the most prevalent underlying health conditions
for individuals with COVID-19. These conditions have demonstrated an increase
in morbidity of the virus.2, 3, 4, 5, 6, 7. 8, 9 As of May 18th, 2020, the CDC reported
8,134 (76.4%) of deaths from COVID 19 to be associated with at least one
underlying medical condition (including 83.1% of deaths for those under 65
years). The most common being cardiovascular disease (60.9%), diabetes
mellitus (39.5%), chronic kidney disease (20.8%), and chronic lung disease
(19.2%).7
SES is a complex composition of social and economic factors that
influence an individual, or a community’s experiences. Socioeconomic status
(SES) plays a substantial role in an individual’s life due to the resources and
opportunities that come along with it such as education, quality healthcare access,
financial stability, social status, and race/ethnicity as a socioeconomic factor.38
Individuals from lower SES are at a higher risk for illness susceptibility and
severity.12,13 This is especially prevalent during the current pandemic, where daily
life has drastically changed, including detrimental social and financial challenges
for many. Psychological stress due to restrictions on social behavior, the ability
to see loved ones, and having an unstable occupation, has created outcomes such
as depression, health anxiety, and financial worry.18 Low SES can aggravate these
outcomes due to the higher likelihood of risk factors such as pre-existing financial
instability, lack of healthcare access, and the higher prevalence of pre-existing
diseases associated with COVID-19 such as asthma, CVD, hypertension, chronic
kidney disease (CKD), diabetes, and obesity.10, 9, 19, 20 Therefore, it is essential to
examine the role of SES during the COVID-19 pandemic to be better prepared to
protect the most at-risk populations and find room for improvement in the
1
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healthcare system that would support optimal prevention and treatment of such a
virus universally.
The Complex Role of SES as a Risk Factor for COVID-19 Severity and
Susceptibility
Current trends are highlighting the association between COVID-19 rates
and SES, as well as race/ethnicity. New York City is an important example, as it
experienced the highest rates of infections in the United States.10 The Bronx, a
borough of New York City, has disproportionate rates of hospitalization and
death than any other region within the city. It also ranks last in New York State
for health outcomes, quality of life, and socioeconomic factors,9 while
consistently showing the highest rates of hypertension, diabetes, and asthma,
exacerbated by their socioeconomic conditions.10 Furthermore, Palaiodimos et al.,
found obesity to be the most significant factor in COVID-19 mortality and
severity, even after adjusting for other clinical characteristics such as diabetes,
coronary artery disease, heart failure, COPD, CKD, and smoking. Comparingly,
about 33% of residents in the Bronx are obese, more than any other borough in
New York City. Diabetes and hypertension are also most prevalent in the Bronx
compared to other New York counties.9 These associations are not exclusive to
New York City. According to the CDC, the age-adjusted hospitalization rates for
African-American, Alaska Native, and American Indian populations are 5 times
that of White people. Hospitalization rates for Hispanic/Latino ethnicity are 4
times that of Non-Hispanic White people.39 Black, Asian, and Minority Ethnic
(BAME) populations are at increased risk for poor health outcomes due to
socioeconomic inequalities such as less access to healthcare, and higher rates of
disease such as diabetes, hypertension, obesity, and cardiovascular conditions.35,36
The association between COVID-19 infection and SES is becoming more
clear and is consistent with previous pandemics such as the 2009/2010 H1N1
outbreak.9,11 These inequalities can be contributed to differences in living
conditions, occupation, and systemic challenges.9 Pre-existing inequalities have
been reinforced by the COVID-19 pandemic. For example, the CDC reported that
33% of COVID infections were represented by Black Americans in a study of 99
counties, despite making up 18% of the population. Black counties also
experience six times the death rate compared to the majority of White counties.25
Similarly in Chicago, African American residents represented 72 percent of
COVID-19 deaths, while making up only 29 percent of Chicago's population in
April of 2020.28 Golestaneh et al., also found Black Americans to be more likely
to test positive and be hospitalized due to COVID-19 even when clinical and
sociodemographic factors were adjusted.25 Such differences can be related to
several factors, such as minority populations having higher rates of
comorbidities, lower SES (thus lower chance of access to care), and the fact that
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the majority of front-line workers are of minority and low SES backgrounds.27
Financial distress and poor health care access are linked to adverse health
outcomes and heavier disease burden over the course of life. This is significant as
we know that older populations are at particularly higher risk for COVID-19 and
experience worse morbidity and mortality.26 Income inequality within society has
damaging effects on the physical and social well-being of populations.13 In a
longitudinal analysis by Robinette et al., the chance of developing and/or having
more than two chronic health conditions decreased for every 10,000 dollar
increment in neighborhood income.12
The Distressed Communities Index (DCI) can be a useful tool to
quantitatively examine the relationships between SES and health outcomes such
as with COVID-19. The DCI accounts for seven socioeconomic factors such as
unemployment, education, poverty rate, median income, business growth, and
housing vacancies. A higher county DCI score was associated with more
COVID-19 deaths per 100,000 people than non-distressed counties. While this
can be explained by the higher prevalence of comorbidities and age, the
association between COVID-19 mortality and socioeconomic status was stronger
than that with underlying medical conditions.29
Pre-existing medical conditions are well known to put an individual at a
much higher risk for poor COVID-19 outcomes. However, pre-existing medical
conditions on their own do not represent the most accurate estimation for
infection severity and susceptibility. Exposure to the virus and access to optimal
treatment and preventative care is very significant when examining vulnerability
to COVID-19 and predicting the severity of prognosis. The work of Wiemer et al.
uses a predictive model to examine the vulnerability to “in-patient hospitalization
for respiratory conditions for the U.S. and how vulnerability varies by education,
income, and race-ethnicity” using an index of relative vulnerability (VI).2
Substantial differences in vulnerability are found due to inequalities across race
and socioeconomic status particularly in terms of pre-existing health conditions.
Notably, these disparities are present earlier in life, before age 65. Non-Hispanic
(NH) Blacks were found to have more risk factors on average than Non-Hispanic
Whites, including a higher prevalence of hypertension but had lower VI among
all ages. Vulnerability was found to be 60% higher for those with an education of
high school or less than with a college degree, and VI was higher for those in the
lower quartile of household income across all age groups. Among those who are
25 years or older, a 3-fold difference was found between individuals in the lowest
quartile of household income than those in the top quartile. Wiemer makes the
important distinction between exposure and susceptibility to infection. While no
difference was found in vulnerability index (VI) between NH Blacks and NH
Whites, when examined within age groups (specifically 45-64, 65+) NH Blacks
had higher VI. This points to significant differences in exposure that can be
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related to varying health conditions among the two populations. Likewise,
Hispanics were found to have lower VI than NH Whites and NH Blacks despite
high hospitalization rates, suggesting significant exposure rates.2
Linking SES and Poor Health Outcomes from a Biological Perspective
Low socioeconomic status can be a source of psychological stress for
individuals and families due to financial and social burdens. When the stressors
associated with low SES are experienced early in life, and/or consistently
throughout life, overall health is at risk. Thus, during a pandemic of a highly
contagious virus such as COVID-19, SES becomes a risk factor for increased
severity of infection. A growing body of evidence is continuing to reveal the
biological link between low SES and adverse effects such as cellular
senescence.14, 15, 17 Cellular senescence refers to the cessation of cell division.
Chronic cellular senescence can occur in response to long-term stress and
negatively impacts the immune system.17,42 A study by Elwenspoek et al., found
that in a group of healthy participants, early life adversity (ELA), promoted
cytomegalovirus (CMV), an important driving force of immunosenescence--the
progressive decline of the immune system.17 Low SES was also shown by Dowd
& Aiello to be associated with an impaired immune response to CMV. This
further suggests that low SES is a risk factor for worse health outcomes and
poorer immune response to infection.37
The relationship between immune dysfunction, ELA, and SES is critical
towards understanding the role SES has on the severity and susceptibility of
COVID-19. Data has shown that a dysfunctional immune cell response and
abundance of senescent cells, will negatively impact the prognosis of COVID-19.
Senescent immune cells produce pro-inflammatory cells16 and show elevated
levels of cytotoxicity.17 Accelerated and chronic immunosenescence of cells
would lead to a higher likelihood of mortality and morbidity of disease.21 Severe
COVID-19 patients have more non-functional, and senescent immune cells, as
well as increased cytokine release storm which is an inflammatory response by
immune cells to endogenous/exogenous stress. Thus, COVID-19 can mimic
immunosenescence, as outlined by Omarjee et al.24 Proper immune function is
necessary for the least severe COVID-19 outcome.16 The association between an
altered immune response to infection and SES highlights one way in which low
SES individuals are especially vulnerable to COVID-19 severity and
susceptibility. It is important to address the challenges associated with low SES,
to ensure proper prevention and treatment of COVID-19 and other infectious
diseases. Prevention strategies can include mental health screenings, counseling
services, and access to primary care for low SES communities.
Improving Access to Care and Rethinking the Healthcare System for Health
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Equity

It has become clear that significant discrepancies exist within different
populations of society. Data has pointed to disproportionate COVID-19 infection
rates, illness severity, susceptibility, and morbidity. To address these issues,
access to care must be held as a priority. Challenges within the healthcare system
should be improved and acknowledged. Even before the COVID-19 pandemic,
socioeconomic inequalities have been a barrier to receiving healthcare, especially
primary care facilities that include not only treatment but preventative services.
The U.S. has struggled to provide affordable access to care even before the
pandemic, and now these issues are becoming more prevalent. In 2018,
approximately 8.5% of the population (27.5 million people) were uninsured. This
is important as the majority of the population receives insurance through their
employer, employer-sponsored insurance (ESI). During an economic crisis
exasperated by a pandemic, job loss is high and thus health insurance is low
when it is needed most. As of April of 2020, the unemployment rate hit 14.7%,
the lowest since World War II.30 And, if employment is not lost, health insurance
coverage could still be at risk due to employers cutting costs. On the other hand, a
public insurance system could unlink employment and insurance, improving some
of the downfalls of private insurance.31 The quality of health coverage is
influenced by the premium paid per month, meaning quality care decreases with
lower income. This can also influence whether an individual seeks care due to
extra costs from copays, even with ESI.34 Likewise, in a poll regarding seeking
care during COVID-19, 68% of Americans state they would delay or avoid
seeking care if they suspected having symptoms of the virus due to cost.33 Similar
reluctances to seek care was observed in another survey further emphasizing the
association between SES and unwillingness to seek care for financial reasons
during COVID-19.41 Measures such as the Families First Coronavirus Response
Act requires insurers such as Medicare, Medicare Advantage, and Medicaid to
eliminate copayments, deductibles and coinsurance payments for COVID-19
testing services. However, this does not take into account services for treatment
and hospitalization. The same is seen with the Coronavirus Aide, Relief and
Economic Security Act (CARES), where costs associated with treatment are not
addressed.33 Blumenthal et al. highlights the flaws within ESI including the lack
of implementation of laws such as the Affordable Care Act (ACA) due to lack of
education about eligibilities, and that 14 states have opted out of the ACA.31
Smith and Fraser32 outline important strategies for improving systemic
challenges such as improving and expanding data and analytic capabilities,
expanding public health laboratory capacities, and increasing the number of CDC
public health advisors who work with staff in ministries of health and
governmental public health. Furthermore, it is notable that “the budget for the
CDC’s Public Health Emergency Preparedness cooperative agreement has been
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reduced by almost one third” from federal fiscal year (FFY) 2002 to FFY2019
despite congress having invested in federal, state, and local public health
preparedness programs after events of September 11 and the anthrax attack.32
Quality data and analytics are also necessary for adequate disease surveillance
and to make timely, informed decisions. This is significant for reducing
inequalities within SES by providing data on different communities and
ultimately using this to develop prevention and response strategies that will
therefore address the most vulnerable populations, and thus decrease infection
overall. Addressing SES challenges is also essential for disease surveillance as
universal access to care would ensure significantly more individuals being
tested.23 Such strategies can drastically improve the preparedness capabilities of
the public health system. The U.S. had 17.7% of the nation’s gross domestic
product (GDP) spent on healthcare in 2018, compared to the Organization for
Economic Cooperation and Development (OECD) average of 8.8%, with disease
burden being 28% compared to the OECD average of 17.5%. These diseases
include those that put Americans at higher risk of COVID-19: hypertension, heart
disease, diabetes, chronic lung disease.34
Lessons from the Pandemic
While the U.S. population constitutes 6% of the world’s population, the
U.S. represents 26% of COVID-19 cases and 24% of COVID-19 deaths.31 This
alone is cause for more focus on research and implementation of strategies to
address issues within the healthcare system. The relationship between SES and
the health outcomes during the COVID-19 pandemic serves as a lesson to be
learned from. The inequalities we see among different SES populations and raceethnicity can be attributed to a substantial wealth gap, systemic inequalities, and
a flawed healthcare system. Specifically, the COVID-19 pandemic has also
emphasized the crucial need for affordable healthcare that is accessible to all,
regardless of SES. This is necessary for the health of the country, as well as
crucial to properly address public health emergencies such as COVID-19. It is
also important to note that the outcomes of the current pandemic have been
experienced before, such as during the 2009 H1N1 influenza pandemic, where
vulnerable populations experienced the worst outcomes due to poor healthcare
access and increase susceptibility and exposure to the virus.40 By acknowledging
the populations most at risk, the cause of said risk, and addressing preparedness
capacities and strategies outlined above by Smith and Fraser,32 we may be much
better prepared to optimally control public health emergencies. Furthermore, it is
important to implement strategies for increasing data collection of race and
ethnicity such as the Equitable Data Collection and Disclosure on COVID‐19 Act,
which aims to establish a standardized repository for race/ethnicity data related to
COVID‐19.28 Research on the relationship between SES and increased prevalence
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on disease burden is also important as the link has been extensively studied, but
the root cause of this association is not as well known. A public health approach
that recognizes the social, environmental, economic, and personal impact of
health at the individual and community level is necessary to begin to solve such
health disparities.
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